Girls (n = 469) | Boys (n = 443) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline a | End of follow-up a | Crude change | Adjusted difference of intervention vs control b(95% CI) | p | Baseline a | End of follow-up a | Crude change | Adjusted difference of intervention vs control b(95% CI) | p | |
ADIPOSITY | ||||||||||
Overweight or obesity, % | ||||||||||
Control | 30.0 | 31.7 | 1.7 | 0.8c (0.3; 1.7) | 0.53 | 36.5 | 38.5 | 2.0 | 0.7c (0.4; 1.2) | 0.16 |
Intervention | 33.2 | 32.8 | −0.4 | 40.3 | 38.2 | −2.1 | ||||
Underweight, % | ||||||||||
Control | 7.9 | 7.1 | −0.8 | 1.1c (0.3; 4.7) | 0.88 | 9.5 | 8.3 | −1.2 | 0.5c (0.1; 2.1) | 0.38 |
Intervention | 8.7 | 7.4 | −1.3 | 6.3 | 7.3 | 1 | ||||
BMI, kg/m 2 | ||||||||||
Control | 18.7(3.6) | 19.1 (3.7) | 0.4 | −0.2 (−0.4; 0.1) | 0.09 | 19.0 (3.6) | 19.3 (3.7) | 0.3 | 0.01 (−0.1; 0.1) | 0.89 |
Intervention | 18.7 (3.5) | 19.0 (3.5) | 0.3 | 19.3 (3.6) | 19.4 (3.6) | 0.1 | ||||
TST, mm | ||||||||||
Control | 14.5 (5.4) | 17.7 (7.5) | 3.2 | −1.1 (−2.1; −0.7) | 0.02 | 13.4 (5.7) | 16.4 (8.3) | 3.0 | −0.6 (−1.9; 0.8) | 0.43 |
Intervention | 15.7 (5.2) | 18.2 (7.6) | 2.5 | 14.8 (5.6) | 17.3 (8.2) | 2.5 | ||||
Body fat % | ||||||||||
Control | 26.3 (6.0) | 26.3 (6.0) | 0.0 | −0.9 (−1.3; −0.4) | <0.001 | 23.8 (8.3) | 23.6 (7.0) | −0.2 | −0.5 (−1.2; 0.1) | 0.13 |
Intervention | 26.6 (5.8) | 25.9 (5.8) | −0.7 | 24.2 (6.9) | 23.5 (6.7) | −0.7 | ||||
Fat-free mass, kg | ||||||||||
Control | 26.7 (4.8) | 28.5 (5.2) | 1.7 | 0.3 (0.1; 0.6) | 0.04 | 28.0 (4.7) | 29.6 (5.2) | 1.5 | 0.5 (0.2; 0.9) | 0.003 |
Intervention | 26.5 (4.6) | 28.6 (4.9) | 2.1 | 28.1 (4.6) | 29.8 (4.5) | 1.7 | ||||
Waist circumference, cm | ||||||||||
Control | 66.2 (8.8) | 68.5 (9.1) | 2.3 | −2.7 (−4.5; −0.9) | 0.01 | 68.1 (9.3) | 69.9 (9.9) | 1.8 | −1.4 (−2.6; −0.1) | 0.03 |
Intervention | 67.1 (8.9) | 67.4 (8.4) | 0.3 | 68.1 (9.7) | 68.7 (9.2) | 0.6 | ||||
CARDIOMETABOLIC RISK FACTORS | ||||||||||
LDL-C, mg/dl | ||||||||||
Control | 94.1 (23.1) | 90.7 (22.2) | −3.5 | −3.8 (−6.9; −0.7) | 0.015 | 92.9 (20.7) | 90.9 (20.9) | −2.0 | −2.7 (−6.9; 1.5) | 0.21 |
Intervention | 100.7 (24.2) | 94.3 (23.1) | −6.4 | 101.1 (24.5) | 97.1 (22.3) | −3.9 | ||||
TGL/HDL-C, mg/dl | ||||||||||
Control | 1.3 (0.9) | 1.3 (0.9) | −0.1 | 0.0 (−0.2; 0.2) | 0.92 | 1.1 (0.8) | 1.0 (0.7) | −0.1 | 0.4 (0.1; 0.8) | 0.02 |
Intervention | 1.3 (1.0) | 1.3 (1.0) | 0.1 | 1.1 (0.8) | 1.2 (1.2) | 0.1 | ||||
Insulin, μU/mL | ||||||||||
Control | 8.1 (4.1) | 9.7 (7.3) | 1.6 | −2.3 (−3.7; −0.8) | 0.002 | 7.1 (5.5) | 7.9 (6.9) | 0.8 | −0.04 (−2.3; 2.2) | 0.97 |
Intervention | 9.0 (5.4) | 8.9 (5.0) | −0.1 | 7.6 (3.9) | 8.0 (7.2) | 0.4 | ||||
CRP, mg/L | ||||||||||
Control | 1.4 (2.4) | 1.6 (2.5) | 0.2 | 0.1 (−0.5; 0.7) | 0.83 | 1.4 (2.1) | 1.7 (2.5) | 0.3 | −0.3 (−1.3; 0.8) | 0.62 |
Intervention | 1.5 (2.1) | 1.7 (2.2) | 0.2 | 1.4 (2.1) | 1.6 (2.3) | 0.2 | ||||
MAP, mm Hg | ||||||||||
Control | 75.1 (6.3) | 76.5 (6.9) | 1.4 | −0.2 (−2.5; 2.2) | 0.89 | 75.8 (7.4) | 76.8 (7.3) | 1.04 | 0.7 (−1.8; 3.1) | 0.60 |
Intervention | 74.0 (7.6) | 76.3 (6.9) | 2.3 | 74.7 (6.9) | 77.2 (6.0) | 2.45 | ||||
TG/HDL-C, mg/dl |